Hoth Therapeutics, Inc. logo

HOTHHoth Therapeutics, Inc.

HOTH Stock Price, Valuation & Chart | Hoth Therapeutics, Inc.

Compare

HOTH Historical price chart

HOTH Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization10.62M
PE Ratio-1.0
EPS-0.8
Trading Volume40.06K
Today's High/Low0.83/0.79
Dividend Yield0.00
52 Week High/Low2.45/0.49
Shares Outstanding13.26M
HOTH Financial Statement
HOTH Analyst ratings
HOTH Analysis & performance metrics

HOTH Company profile

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a…

HOTH Management team

Management
Robb KnieCEO
Founder, President, Chief Executive Officer & Chairman
David S. BrionesCFO
Chief Financial Officer
Hayley Springer
Executive Vice President of Operations
Total 3 executives

HOTH Frequently asked questions

What is Hoth Therapeutics, Inc. (HOTH) Stock Price?

Current stock price of Hoth Therapeutics, Inc. (HOTH) stock is $0.800. The stock price is -2.22% lower in the session. The intraday range can be seen from this page. Volume of Hoth Therapeutics, Inc. (HOTH) stock is 40.06K.

Last updated at 05 Aug 2026, 07:59 pm.

Why is the Hoth Therapeutics, Inc. (HOTH) stock price going up or down today?

The stock price of Hoth Therapeutics, Inc. (HOTH) can change with earnings, company news, and overall market sentiment. Hoth Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Hoth Therapeutics, Inc. stock expensive at its current price?

Whether Hoth Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HOTH on this page is -1.00. EPS on this page is -0.80. Compare those figures with peers and growth expectations before deciding if the current Hoth Therapeutics, Inc. price is justified.

How has the stock price of Hoth Therapeutics, Inc. (HOTH) performed historically?

Historical performance for Hoth Therapeutics, Inc. (HOTH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HOTH reacted to past earnings and market events.

Should I buy Hoth Therapeutics, Inc. (HOTH) stock, at this price?

Buying Hoth Therapeutics, Inc. (HOTH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.